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Background: Methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis and coagulase-negative Staphylococ-
cus infections are a worldwide concern. Terminalia ivorensis, of  Combretaceae family plant, is widely used traditional me-
dicinal in Côte d’Ivoire to treat dermal diseases (affection in which Staphylococci are implied) including local inflammation 
and also to treat voice-loss. 
Objectives: This study focused to investigate the effect in vitro of  the extracts of  trunk barks of  Terminalia ivorensis on 
some methicillin/oxacillin-resistant strains of  Staphylococcus aureus, S. epidermidis, coagulase-negative S. and reference 
strain of  S. aureus ATCC 25923. 
Methods: Antibacterial activity of  aqueous, 70% ethanolic 70% and aqueous residue extracts was assessed using agar 
disc-diffusion method and liquid medium microdilution method in 96 multi-well micro-titer plates. This method led us to 
determine minimum inhibition concentration (M.I.C.) and minimum bactericidal concentration (M.B.C.). The presence of  
chemical groups major was detected qualitatively.
Results: Aqueous and 70% ethanolic 70% extracts showed significant activity against all the bacteria except aqueous residue 
when compared with the standard antibiotic oxacillin (5µg/ml). M.I.C. for aqueous and 70% ethanolic 70% extracts ranged 
from 0,83-16,67 mg/ml and 0,156-13,33 mg/ml respectively. Viable cell determination revealed the bactericidal nature of  
the two barks extracts. The 70% ethanolic 70% extract exhibited the highest activity according to the M.B.C. values. The 
phytochemical analysis indicates the presence of  tannins, saponins, flavonoids, terpen/sterols, coumarins, polyphenols and 
traces of  alkaloid.
Conclusion: The in-vitro antibacterial efficacy shown by the barks of  this plant and his lushness in chimical compounds, 
would justify use of  this one in the traditional treatment of  some diseases of  microbial origin. These compounds could be 
suggested to provide alternative solution to the development of  new therapeutic agents. 
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Introduction
         The treatment of  the bacterial infections is in 
general based on the use of  antibiotics. Very great often 
unsuited use of  these molecules antibacterial drove the 
selection of  strains multi-resistant bacteria. It is the case 
for example producing bacteria of  penicillinase, resist-
ant to all them penicillin such as the penicillin of  group 
A, G and M. Methicillin/oxacillin-resistant staphyloco-
cci infections mainly caused by Staphylococcus aureus 
and by coagulase-negative staphylococci, as S. epider-
midis are considered one of  the major man pathogenic, 
causing infections of  the skin and fabrics soft. 
         In Côte d’Ivoire like in the either developing coun-
tries, infectious caused by methicillin/oxacillin-resistant 
Staphylococcus spp. continues to be a growing pub-
lic health concern. Numerous cases of  multi-resistant 
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bacteria were reported1; 2; 3. The Staphylococci are in-
volved in various sicknesses and often responsible for 
infections most frequently contracted in hospitals in 
nosocomial infections cases4; starting by simple whit-
low to the most serious infections like septicaemias, en-
docarditis, major pneumonias, cellulites and abscesses5; 
6. These bacteria give an important number of  toxins 
and extracellular enzymes, and fights against the action 
of  the methicillin/oxacillin and its by-products. So, the 
effectiveness of  antibiotics, considered as the quasi-
universal solution to infections, decreases. Face to the 
weaknesses of  chemotherapy, it is more necessary than 
and the necessity to find other alternative means in the 
fight against this resistance. it It is thus significant to di-
rect research towards new ways and especially towards 
the plants which always have been used as a basis for 
new drugs.
       Terminalia ivorensis A. Chev. (Combretaceae) is 
a woody species belonging to the category I of  the 
commercial sawlog of  Côte d'Ivoire. The trunk barks 
presents a rhytidom peeling of  the tree in sheets (fig. 1). 
Its common name is Framiré. In Côte d'Ivoire, the root 
of  this plant is used against voice-loss, and as antipy-
retic7; 8. The trunk barks are We also used
the trunk barks as  against woundwort9 and against 
some cutaneous affection.
       Our study consisteds of  the research of  the antimi-
crobial activity biological activity of  the aqueous, 70% 
ethanolic and aqueous residue extracts of  the trunk 
barks of  Terminalia ivorensis A. Chev. (Combretaceae) 
against opposite some bacterial methicillin/oxacillin-
resistant bacteria strains of  Staphylococcus spp., which 
implied in some dermal diseases,. in other to verify its 
claimed ethno-medicinal use in the treatment of  skin 





         The trunk barks part of  T. ivorensis was collected 
in Tiassalé, Côte d’Ivoire, in December 2008, and iden-
tified by Pr Aké-Assi of  the Laboratory of  Vegetable 
Biology University Félix Houphouët Boigny of  Coco-
dy-Abidjan. A voucher specimen (voucher n° 8855) is 
deposited in the Herbarium of  National Floristic Cent-
er of  Abidjan.
Bacterial strains 
Microorganisms were obtained from the Laboratory of  
Bacteriology-Virology of  the Institute Pasteur of  Côte 
d'Ivoire. They consist of:
•      01 strain reference of  Staphylococcus aureus ATCC 
25923 
•      14 strains of  S. aureus resistant to oxacillin, cefoxi-
tine, rifampicin, ciprofloxacin, tetracycline, gentamycin 
and some to vancomycin.
•      01 strain of  S. epidermidis resistant to cefoxitine, 
cotrimoxazol, erythromycin, ciprofloxacin, oxacillin 
and gentamycin.
•      04 strains of  coagulase-negative Staphylococcus 
resistant to fusidic acid, cefoxitin, erythromycin, fosfo-
mycine, cotrimoxazol and oxacillin. 
    Preparation of  extracts  
1.    Aqueous extract23 and N’guessan9.  affections in 
which the staphylococci are implied. 
       The phytochemical screening of  the extract of  the 
trunk barks of  T. ivorensis has shown the presence of  
saponins, terpens, tannins, polyphenols. These classes 
of  secondary metabolites are known to possess antibac-
terial activities24. This would explain the bactericidal 
action of  the trunk barks of  T. ivorensis.  However, 
negative results observed with aqueous residue, do not 
mean absence of  bioactive constituents nor is that the-
extract inactive. Active compounds may be present but 
in insufficient quantities in this crude extract to show 
activity with the dose levels employed25 or it could be 
that its activity is masked by the presence of  sugars26. 
We could deduce from that the antibacterial substances 
contained in the trunk barks of  T. ivorensis are more 
soluble in the 70% ethanol at 70% than in water used. 
The ethanol would then concentrate better the active 
ingredient27. The presence of  those active principles 
would then justify the use of  that plant in the treatment 
of  the skin troubles and local inflammation in the Ivo-
rian traditional pharmacopeia. 
 
Conclusion: 
       The lushness of  the extracts in chimical com-
pounds, would justify their therapeutic effects and over-
coat the use of  this plant in the traditional treatment of  
some diseases of  microbial origin. Isolation and purifi-
cation of  different compounds could be suggested to 
provide alternative solution to the development of  new 
therapeutic agents. This study showed us that the aque-
ous and ethanolic 70% extracts were bactericidal on the 
whole bacterial strains at the origin of  some infections 
in the human and suggest, these extract can provide al-
ternative solution for the treatment of  dermal diseases 
particularly in Côte d’Ivoire where this pathology is al-
ways a public health problem. 
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